Local TNF causes NFATc1-dependent cholesterol-mediated podocyte injury

Overview of attention for article published in Journal of Clinical Investigation, August 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

news: 1 news outlet
twitter: 7 X users

patent: 7 patents
facebook: 1 Facebook page

Readers on

mendeley: 91 Mendeley
citeulike: 1 CiteULike

So far, Altmetric has seen 7 patents that reference this research output.

Compounds for use in the treatment of kidney damage

Grant JP-7879183-B2

Japan

23 Jun 2026

COMPOUNDS FOR USE IN TREATING KIDNEY DISORDERS

Application JP-2024096989-A

Japan

17 Jul 2024

GENISTEIN FOR USE IN THE TREATMENT OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS)

Application WO-2022117864-A1

World Intellectual Property Organisation (WIPO)

09 Jun 2022

CLOPIDOGREL FOR USE IN THE TREATMENT OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS)

Application WO-2022117862-A1

World Intellectual Property Organisation (WIPO)

09 Jun 2022

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 3 additional patents.